Tredje AP-fonden’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.67M | Sell |
26,762
-19,827
| -43% | -$3.89M | 0.03% | 375 |
|
|
2026
Q1 | $9.13M | Buy |
46,589
+33,372
| +252% | +$6.48M | 0.05% | 331 |
|
|
2025
Q4 | $2.29M | Sell |
13,217
-19,374
| -59% | -$3.53M | 0.02% | 280 |
|
|
2025
Q3 | $6.21M | Buy |
32,591
+2,490
| +8% | +$442K | 0.05% | 144 |
|
|
2025
Q2 | $5.41M | Buy |
30,101
+7,761
| +35% | +$1.35M | 0.04% | 136 |
|
|
2025
Q1 | $3.78M | Buy |
22,340
+13,593
| +155% | +$2.23M | 0.04% | 170 |
|
|
2024
Q4 | $1.32M | Sell |
8,747
-8,746
| -50% | -$1.36M | 0.01% | 347 |
|
|
2024
Q3 | $2.72M | Hold |
17,493
| – | – | 0.02% | 312 |
|
|
2024
Q2 | $2.39M | Sell |
17,493
-276
| -2% | -$37.8K | 0.02% | 322 |
|
|
2024
Q1 | $2.37M | Hold |
17,769
| – | – | 0.02% | 336 |
|
|
2023
Q4 | $2.45M | Sell |
17,769
-721
| -4% | -$94.8K | 0.03% | 338 |
|
|
2023
Q3 | $2.25M | Sell |
18,490
-1,703
| -8% | -$227K | 0.03% | 339 |
|
|
2023
Q2 | $2.84M | Sell |
20,193
-3,956
| -16% | -$545K | 0.04% | 312 |
|
|
2023
Q1 | $3.42M | Buy |
24,149
+576
| +2% | +$82.4K | 0.05% | 257 |
|
|
2022
Q4 | $3.69M | Buy |
23,573
+1,551
| +7% | +$223K | 0.06% | 227 |
|
|
2022
Q3 | $2.7M | Buy |
+22,022
| New | +$2.9M | 0.06% | 262 |
|
|
2020
Q1 | – | Sell |
-14,948
| Closed | -$1.6M | – | 281 |
|
|
2019
Q4 | $1.6M | Buy |
14,948
+2,159
| +17% | +$225K | 0.08% | 255 |
|
|
2019
Q3 | $1.37M | Sell |
12,789
-189
| -1% | -$19.4K | 0.07% | 280 |
|
|
2019
Q2 | $1.32M | Sell |
12,978
-12,648
| -49% | -$1.22M | 0.06% | 289 |
|
|
2019
Q1 | $2.3M | Buy |
25,626
+7,659
| +43% | +$664K | 0.12% | 199 |
|
|
2018
Q4 | $1.5M | Buy |
17,967
+8,039
| +81% | +$754K | 0.09% | 219 |
|
|
2018
Q3 | $1.07M | Sell |
9,928
-50,630
| -84% | -$5.55M | 0.05% | 293 |
|
|
2018
Q2 | $6.66M | Buy |
60,558
+23,548
| +64% | +$2.45M | 0.23% | 135 |
|
|
2018
Q1 | $3.71M | Sell |
37,010
-5,080
| -12% | -$520K | 0.13% | 194 |
|
|
2017
Q4 | $4.14M | Sell |
42,090
-15,910
| -27% | -$1.51M | 0.14% | 183 |
|
|
2017
Q3 | $5.43M | Buy |
58,000
+15,830
| +38% | +$1.68M | 0.19% | 132 |
|
|
2017
Q2 | $4.69M | Sell |
42,170
-540
| -1% | -$57.1K | 0.17% | 160 |
|
|
2017
Q1 | $4.19M | Buy |
42,710
+6,062
| +17% | +$578K | 0.17% | 174 |
|
|
2016
Q4 | $3.37M | Buy |
36,648
+13,108
| +56% | +$1.13M | 0.14% | 196 |
|
|
2016
Q3 | $2M | Buy |
23,540
+4,374
| +23% | +$367K | 0.09% | 261 |
|
|
2016
Q2 | $1.56M | Buy |
19,166
+8,906
| +87% | +$678K | 0.07% | 264 |
|
|
2016
Q1 | $782K | Buy |
+10,260
| New | +$688K | 0.04% | 291 |
|
Other funds holding DGX
EIG
Tredje AP-fonden's DGX Position: Q2 2026 in Review
Tredje AP-fonden reduced its Quest Diagnostics (DGX) stake by 43% in Q2 2026, selling an estimated $3.89M and leaving 26,762 shares worth $5.67M. The position accounts for 0.03% of the portfolio, ranked #375.
Tredje AP-fonden first reported a position in DGX in Q1 2016 and has held it in 32 quarters since. The position peaked at $9.13M in Q1 2026. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Tredje AP-fonden held 26,762 shares of Quest Diagnostics worth $5.67M as of Q2 2026.
- Tredje AP-fonden sold 19,827 Quest Diagnostics shares in Q2 2026, an estimated $3.89M.
- Quest Diagnostics made up 0.03% of Tredje AP-fonden's portfolio in Q2 2026, its #375 holding.
- Tredje AP-fonden first reported a position in Quest Diagnostics in Q1 2016 and has held it in 32 quarters since.
- Tredje AP-fonden's Quest Diagnostics position peaked at $9.13M in Q1 2026.
- 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Tredje AP-fonden's 13F filing for Q2 2026, filed 10 Aug 2026.